<DOC>
	<DOC>NCT01435408</DOC>
	<brief_summary>This study focuses on Cardioprotective strategies.</brief_summary>
	<brief_title>DANish Study of Optimal Acute Treatment of Patients With ST-elevation Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Age ≥ 18 years. Acute onset of chest pain of &lt; 12 hours' duration. STsegment elevation ≥ 0.1 mV in ≥ 2 contiguous leads, signs of a true posterior infarction or documented newly developed left bundle branch block. Culprit lesion in a major native vessel. Pregnancy. Known intolerance of ASA, clopidogrel, heparin or contrast. Inability to understand information or to provide informed consent. Haemorrhagic diathesis or known coagulopathy. Stent thrombosis.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>STEMI</keyword>
	<keyword>Ischemic postconditioning</keyword>
	<keyword>Deferred stenting</keyword>
	<keyword>Primary PCI</keyword>
</DOC>